VitaNova Life Sciences Corporation Income (Loss) from Equity Method Investments
VitaNova Life Sciences Corporation (VNOV) reported Income (Loss) from Equity Method Investments of -$92.57 thousand for the 9-month period ending 2019-01-31, per its 10-Q filed 2019-03-15.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2019-03-15
- VitaNova Life Sciences Corporation income (loss) from equity method investments for the quarter ending 2019-01-31 was -$36.70K.
- VitaNova Life Sciences Corporation income (loss) from equity method investments for the quarter ending 2018-01-31 was -$12.75K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month |
|---|---|---|---|
| 2019-01-31 | -$36.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-15 | -$92.57K 10-Q · filed 2019-03-15 | |
| 2018-10-31 | -$55.88K 10-Q · filed 2018-12-14 | ||
| 2018-01-31 | -$12.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-15 | $2.60K 10-Q · filed 2019-03-15 | |
| 2017-10-31 | $15.35K 10-Q · filed 2018-12-14 |